Literature DB >> 19262176

The role of cathepsin X in cell signaling.

Janko Kos1, Zala Jevnikar, Natasa Obermajer.   

Abstract

Cathepsin X is a lysosomal cysteine protease, found predominantly in cells of monocyte/macrophage lineage. It acts as a monocarboxypepidase and has a strict positional and narrower substrate specificity relative to the other human cathepsins. In our recent studies we identified-beta(2) subunit of integrin receptors and alpha and gamma enolase as possible substrates for cathepsin X carboxypeptidase activity. In both cases cathepsin X is capable to cleave regulatory motifs at C-terminus affecting the function of targeted molecules. We demonstrated that via activation of beta(2) integrin receptor Mac-1 (CD11b/CD18) active cathepsin X enhances adhesion of monocytes/macrophages to fibrinogen and regulates the phagocytosis. By activation of Mac-1 receptor cathepsin X may regulate also the maturation of dendritic cells, a process, which is crucial in the initiation of adaptive immunity. Cathepsin X activates also the other beta(2) integrin receptor, LFA-1 (CD11a/CD18) which is involved in the proliferation of T lymphocytes. By modulating the activity of LFA-1 cathepsin X causes cytoskeletal rearrangements and morphological changes of T lymphocytes enhancing ameboid-like migration in 2-D and 3-D barriers and increasing homotypic aggregation. The cleavage of C-terminal amino acids of alpha and gamma enolase by cathepsin X abolishes their neurotrophic activity affecting neuronal cell survival and neuritogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262176      PMCID: PMC2679876          DOI: 10.4161/cam.3.2.7403

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  28 in total

1.  Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.

Authors:  J Sivaraman; D K Nägler; R Zhang; R Ménard; M Cygler
Journal:  J Mol Biol       Date:  2000-01-28       Impact factor: 5.469

2.  Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion.

Authors:  Joanna C Porter; Madelon Bracke; Andrew Smith; Derek Davies; Nancy Hogg
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

3.  Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.

Authors:  C Therrien; P Lachance; T Sulea; E O Purisima; H Qi; E Ziomek; A Alvarez-Hernandez; W R Roush; R Ménard
Journal:  Biochemistry       Date:  2001-03-06       Impact factor: 3.162

4.  Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase.

Authors:  I Klemencic; A K Carmona; M H Cezari; M A Juliano; L Juliano; G Guncar; D Turk; I Krizaj; V Turk; B Turk
Journal:  Eur J Biochem       Date:  2000-09

5.  Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa.

Authors:  Frank Bühling; Ulrich Peitz; Sabine Krüger; Dörthe Küster; Michael Vieth; Ingrid Gebert; Albert Roessner; Ekkehard Weber; Peter Malfertheiner; Thomas Wex
Journal:  Biol Chem       Date:  2004-05       Impact factor: 3.915

6.  Cysteine cathepsins (proteases)--on the main stage of cancer?

Authors:  Vito Turk; Janko Kos; Boris Turk
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

7.  Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.

Authors:  Natasa Obermajer; Urban Svajger; Mathew Bogyo; Matjaz Jeras; Janko Kos
Journal:  J Leukoc Biol       Date:  2008-08-13       Impact factor: 4.962

8.  Maturation of DC is associated with changes in motile characteristics and adherence.

Authors:  Siobhan Burns; Samantha J Hardy; Joanna Buddle; Kwee L Yong; Gareth E Jones; Adrian J Thrasher
Journal:  Cell Motil Cytoskeleton       Date:  2004-02

9.  Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.

Authors:  Dorit K Nägler; Sabine Krüger; Angela Kellner; Edmund Ziomek; Robert Menard; Peter Buhtz; Matthias Krams; Albert Roessner; Udo Kellner
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

Review 10.  Integrin cytoplasmic domain-binding proteins.

Authors:  S Liu; D A Calderwood; M H Ginsberg
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  32 in total

1.  Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice.

Authors:  Jiusong Sun; Galina K Sukhova; Jie Zhang; Han Chen; Sara Sjöberg; Peter Libby; Mingcan Xia; Na Xiong; Bruce D Gelb; Guo-Ping Shi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

Review 2.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

3.  The function of cathepsins B, D, and X in atherosclerosis.

Authors:  Caroline F Zhao; David M Herrington
Journal:  Am J Cardiovasc Dis       Date:  2016-11-30

4.  Development of activity-based probes for cathepsin X.

Authors:  Margot G Paulick; Matthew Bogyo
Journal:  ACS Chem Biol       Date:  2011-02-28       Impact factor: 5.100

Review 5.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

6.  Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.

Authors:  Jimmy L Huynh; Paras Garg; Tin Htwe Thin; Seungyeul Yoo; Ranjan Dutta; Bruce D Trapp; Vahram Haroutunian; Jun Zhu; Michael J Donovan; Andrew J Sharp; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2013-11-24       Impact factor: 24.884

7.  Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.

Authors:  Tjasa Vizin; Ib Jarle Christensen; Hans Jørgen Nielsen; Janko Kos
Journal:  Radiol Oncol       Date:  2012-07-24       Impact factor: 2.991

8.  Profilin 1 as a target for cathepsin X activity in tumor cells.

Authors:  Urša Pečar Fonović; Zala Jevnikar; Matija Rojnik; Bojan Doljak; Marko Fonović; Polona Jamnik; Janko Kos
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

9.  Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori.

Authors:  Miha Skvarc; David Stubljar; Andreja Natasa Kopitar; Samo Jeverica; Bojan Tepes; Janko Kos; Alojz Ihan
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

10.  Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.

Authors:  Tjaša Vižin; Ib Jarle Christensen; Michael Wilhelmsen; Hans Jørgen Nielsen; Janko Kos
Journal:  BMC Cancer       Date:  2014-04-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.